Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 57, Issue 5, 1997, Pages 427-434

  Nielsen, F S ^a   Rossing, P ^a   Gall, M A ^a   Smidt, U M ^a   Chen, J W ^a   Sato, A ^a   Parving, H H ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

Antihypertensive treatment; Arterial hypertension; Cardiovascular disease; Transcapillary escape rate of albumin; Urinary albumin excretion rate; Von Willebrand factor

Indexed keywords

ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE; INSULIN; LISINOPRIL; LOOP DIURETIC AGENT; ORAL ANTIDIABETIC AGENT; SERUM ALBUMIN; VON WILLEBRAND FACTOR;

ADULT; AGED; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

GLOMERULUS;

EID: 0030792640     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519709084591     Document Type: Article

References (33)

1. Parving H-H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991; 14: 260-9.
2. Lewis E, Hunsicker L, Bain R, Rhode R. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-62.
3. Nielsen FS, Rossing P, Gall M-A, Skøtt P, Smidt UM, Parving H-H. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 1994; 43: 1108-13.
4. White WB, Pickering TG, Morganroth J, et al. A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens 1991; 4: 890-6.
5. Jamieson MJ, Fowler G, MacDonald TM, et al. Bench and ambulatory field evaluation of the A&D TM-2420 automated sphygmomanometer. J Hypertens 1990; 8: 599-605.
6. Clark S, Fowlie S, Coats A, et al. Ambulatory blood pressure monitoring: validation of the accuracy and reliability of the TM-2420 according to the AAMI recommendations. J Hum Hypertens 1991; 5: 77-82.
7. Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972; 30: 271-4.
8. Parving H-H, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32: 643-51.
9. Parving H-H. Microvascular permeability to plasma proteins in hypertension and diabetes mellitus in man - on the pathogenesis of hypertensive and diabetic microangiopathy. Dan Med Bull 1975; 22: 217-33.
10. Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539-44.
11. Ingerslev J. A sensitive ELISA for von Willebrand factor (vWF : Ag). Scand J Clin Lab Invest 1987; 47: 143-9.
12. Spencer K, Price CP. Kinetic immunoturbidimetry: the estimation of albumin. Clin Chim Acta 1979; 95: 263-76.
13. Gall M-A, Borch-Johnsen K, Nielsen FS, Hougaard P, Parving H-H. Micro- and macroalbuminuria as predictors of mortality in non-insulin-dependent diabetes [abstract]. Diabetologia 1993; 36 Suppl 1: A207.
14. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC. Effect of proteinuria on mortality in NIDDM, Diabetes 1988; 37: 1499-504.
15. Gall M-A, Rossing P, Skøtt P, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-61.
16. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 1987; 3: 463-524.
17. Nielsen FS, Voldsgaard AI, Gall M-A, et al. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1993; 36: 438-44.
18. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-26.
19. Chen J-W, Gall M-A, Deckert M, Jensen JS, Parving H-H. Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. Br Med J 1995; 311: 1405-6.
20. Parving H-H, Nielsen FS, Bang LE, et al. Macromicroangiopathy and endothelial dysfunction in NIDDM patients and without diabetic nephropathy. Diabetologia 1996; 39: 1590-7.
21. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, den Ottolander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340(ii): 319-23.
22. Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G, Navelesi R. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 1995; 18: 1-9.
23. Parving H-H, Smidt UM. Hypotensive therapy reduces microvascular albumin leakage in insulin-dependent diabetic patients with nephropathy. Diabetic Med 1986; 3: 312-15.
24. Parving H-H, Kastrup J, Smidt UM. Reduced transcapillary escape rate of albumin during acute blood pressure-lowering in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1985; 28: 797-801.
25. Sandeman DD, Shore AC, Tooke JE. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 1992; 327: 760-4.
26. Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983; 32: 943-9.
27. Shore AC, Jaap AJ, Tooke JE. Capillary pressure in patients with NIDDM, Diabetes 1994; 43: 1198-202.
28. Williams SA, Boolell M, MacGregor GA, Smaje LH, Wasserman SM, Tooke JE. Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension. Clin Sci 1990; 79: 5-8.
29. Sandeman DD, Shore AC, Tooke JE. Captopril reduces nailfold capillary pressure in type 1 diabetic patients with established nephropathy [abstract]. Diabetic Med 1991; 8: 37A-38A.
30. Shore AC, Donohoe A, Jaap AJ, Tooke JE. Capillary pressure is reduced by ramipril in type 1 diabetic patients with microalbuminuria [abstract]. Diabetologia 1993; 36: A221.
31. Morelli E, Loon N, Meyer TW, Peters W, Myers BD. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990; 39: 76-82.
32. Boneu B, Abbal M, Plante J, Bierne R. Factor-VIII complex and endothelial damage. Lancet 1975; 75(i): 1430.
33. Stehouwer CDA, Donker AJM. Urinary albumin excretion and cardiovascular disease risk in diabetes mellitus: is endothelial dysfunction the missing link? J Nephrol 1993; 6(2): 72-92.